CIViC
Compass
Tumors
Genes
Variants
Evidence
Assertions
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home
/
Biomarker
PTEN loss / mutation (HR+/HER2- breast)
Gene:
PTEN
· Type:
loss
Indications: Breast cancer
Sensitivity
Resistance
CIViC Context
FDA Resistance Assertions
No resistance assertions.